Lincomycin Side Effects
Medically reviewed by Drugs.com. Last updated on Feb 20, 2023.
Applies to lincomycin: injection solution.
Injection route (Solution)
Clostridioides difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including lincomycin, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.Because lincomycin therapy has been associated with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobials agents are inappropriate. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections.C difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C difficile, and surgical evaluation should be instituted as clinically indicated.
Serious side effects of Lincomycin
Along with its needed effects, lincomycin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking lincomycin:
Incidence not known
- Abdominal or stomach pain or tenderness
- black, tarry stools
- blistering, peeling, or loosening of the skin
- blurred vision
- clay-colored stools
- dark urine
- difficulty with swallowing
- dizziness dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- fast heartbeat
- hives, itching, or rash
- joint or muscle pain
- loss of appetite
- lower back or side pain
- painful or difficult urination
- pale skin
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- red skin lesions, often with a purple center
- red, irritated eyes
- severe abdominal or stomach cramps and pain
- sore throat
- sores, ulcers, or white spots in the mouth or on the lips
- tightness in the chest
- ulcers, sores, or white spots in the mouth
- unpleasant breath odor
- unusual bleeding or bruising
- unusual tiredness or weakness
- vomiting of blood
- watery and severe diarrhea, which may also be bloody
- yellow eyes or skin
Other side effects of Lincomycin
Some side effects of lincomycin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- Abdominal or stomach discomfort
- continuing ringing or buzzing or other unexplained noise in the ears
- feeling of constant movement of self or surroundings
- hearing loss
- pain, redness, or hard lumps at the injection site
- redness, swelling, or soreness of the tongue
- sensation of spinning
- sleepiness or unusual drowsiness
For Healthcare Professionals
Applies to lincomycin: compounding powder, injectable solution, oral capsule.
The onset of pseudomembranous colitis symptoms has been reported during and after antibacterial therapy.
Frequency not reported: Glossitis, stomatitis, nausea, vomiting, abdominal distress, persistent diarrhea, enterocolitis, antibacterial-associated diarrhea and colitis, pruritus ani, pseudomembranous colitis, Clostridium difficile associated diarrhea, esophagitis[Ref]
Some hypersensitivity reactions occurred in penicillin-sensitive patients.
A 19-year-old male patient, who had received 2 previous IM injections of lincomycin at the age of 17 years and 1 IM injection 2 weeks prior, reported that a few minutes after his fourth IM injection he noticed a tingling sensation around his face and mouth. The patient's symptoms progressed to bright red to blue-violet skin discoloration, injection of the bulbar conjunctivae, and swelling of his face, neck, and ears. The patient recovered without incident after receiving adrenaline and betamethasone IM followed by oral prednisone with an antihistamine.[Ref]
Rare (less than 0.1%): Exfoliative and vesiculobullous dermatitis
Cases of hypotension after parenteral administration have been reported, especially after too rapid IV administration. Rare cases of cardiopulmonary arrest have been reported after this drug was administered IV too rapidly. In these cases, the affected patients subsequently tolerated slow infusions. A study that looked at multiple large dose administration of this drug found that when the doses were appropriately diluted and administered more slowly, cardiovascular changes did not occur.[Ref]
Rare (less than 0.1%): Cardiopulmonary arrest
Frequency not reported: Hypotension[Ref]
Frequency not reported: Jaundice, abnormal liver function tests (especially elevated serum transaminase)[Ref]
Rare (less than 0.1%): Renal dysfunction, azotemia, oliguria[Ref]
Rare (less than 0.1%): Proteinuria
Frequency not reported: Vaginitis[Ref]
Frequency not reported: Tinnitus, vertigo, neuromuscular blockade, metallic taste in mouth[Ref]
Frequency not reported:
-IM: Pain following injection, local irritation, pain induration, sterile abscess formation
Frequency not reported: Bulbar conjunctival injection
More about lincomycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: lincomycin derivatives
- En español
Related treatment guides
1. Product Information. Lincocin (lincomycin). Pharmacia and Upjohn. 2001.
2. Jaimes EC. Lincocinamides and the incidence of antibiotic-associated colitis. Clin Ther. 1991;13:270-80.
3. Venning GR. Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed). 1983;286:365-8.
4. Burdon DW. Prophylaxis in surgery. J Antimicrob Chemother. 1981;7 Suppl A:19-25.
5. Phillips I. Past and current use of clindamycin and lincomycin. J Antimicrob Chemother. 1981;7 Suppl A:11-8.
6. Keighley MR, Arabi Y, Matheson D, Alexander-Williams J. Aspects of preventing sepsis in colo-rectal surgery: results of recent clinical trials. J Antimicrob Chemother. 1978;4 Suppl C:33-8.
7. George WL, Sutter VL, Finegold SM. Antimicrobial agent-induced diarrhea--a bacterial disease. J Infect Dis. 1977;136:822-8.
8. Hamilton-Miller JM. Antimicrobial agents acting against anaerobes. J Antimicrob Chemother. 1975;1:273-89.
9. Crapp AR, Powis J, Clark C, Keighley MR, Alexander-Williams J. Letter: Postoperative pseudomembranous colitis. Br Med J. 1975;3:227.
10. Wilson DH, Cunliffe WJ, Tan SG. Letter: Lincomycin and clindamycin colitis. Br Med J. 1974;4:288-9.
11. Lincomycin and clindamycin colitis. Br Med J. 1974;4:65-6.
12. Bartlett JG, Sutter VL, Finegold SM. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 1972;287:1006-10.
13. Ashton H, Beveridge GW, Stevenson CJ. Lincomycin and clindamycin. Br J Dermatol. 1970;83:604-6.
14. Sanders E. Lincomycin versus erythromycin: a choice or an echo. Ann Intern Med. 1969;70:585-90.
15. Kaplan K, Weinstein L. Lincomycin. Pediatr Clin North Am. 1968;15:131-9.
16. Bartlett JG. Anti-anaerobic antibacterial agents. Lancet. 1982;2:478-81.
17. Liner SR. Adverse reactions to parenteral lincomycin. Pediatrics. 1981;68:615-6.
18. Berry DD, Brouhard BH, Box QT. Adverse reactions to parenteral lincomycin. Pediatrics. 1981;67:389-91.
19. Robertson MB, Breen KJ, Desmond PV, Mashford ML, McHugh AM. Incidence of antibiotic-related diarrhoea and pseudomembranous colitis: a prospective study of lincomycin, clindamycin and ampicillin. Med J Aust. 1977;1:243-6.
20. McCool D, Miller RR. Treatment of lincomycin-caused diarrhea. JAMA. 1976;236:1937-8.
21. Munk JF, Collopy BT, Connell JL, et al. Lincomycin-clindamycin-associated psuedomembranous colitis. Med J Aust. 1976;2:95-7.
22. Clark CE, Thompson H, Mcleish AR, Powis SJ, Dorricott NJ, Alexander-Williams J. Pseudomembranous colitis following prophylactic antibiotics in bowel surgery. J Antimicrob Chemother. 1976;2:167-73.
23. Boyd WC, DenBesten L. Subtotal colectomy for refractory pseudomembranous enterocolitis. JAMA. 1976;235:181.
24. Kinsella PL. Letter: Antibiotic diarrhoea. Br Med J. 1975;4:580.
25. Parsons RL, Beavis JP, Salfield JB. Letter: Diarrhoea and colitis associated with antibiotic therapy. Br Med J. 1975;4:42.
26. Gibson GE, Rowland R, Hecker R. Diarrhoea and colitis associated with antibiotic treatment. Aust N Z J Med. 1975;5:340-7.
27. Burbige EJ, Milligan FD. Pseudomembranous colitis. Association with antibiotics and therapy with cholestyramine. JAMA. 1975;231:1157-8.
28. Lambert HP. Unwanted effects of antibiotics: some recent additions. J Antimicrob Chemother. 1975;1:2-4.
29. Letter: Lincomycin and clindamycin colitis. Br Med J. 1974;4:591.
30. Scott AJ, Nicholson GI. The recognition of pseudomembranous colitis as a clinical entity. Aust N Z J Med. 1974;4:502-9.
31. Viteri AL, Howard PH, Dyck WP. The spectrum of lincomycin-clindamycin colitis. Gastroenterology. 1974;66:1137-44.
32. Pittman FE, Pittman JC, Humphrey CD. Letter: Lincomycin and pseudomembranous colitis. Lancet. 1974;1:451-2.
33. Scott AJ, Nicholson GI, Kerr AR. Lincomycin as a cause of pseudomembranous colitis. Lancet. 1973;2:1232-4.
34. Marks MI, Shapera RM, Brazeau M. Pediatric antimicrobial therapy 3. Can Med Assoc J. 1973;109:213-4.
35. Novak E, Vitti TG, Panzer JD, Schlagel C, Hearron MS. Antibiotic tolerance and serum levels after intravenous administration of multiple large doses of lincomycin. Clin Pharmacol Ther. 1971;12:793-7.
36. Price DJ, O'Grady FW, Shooter RA, Weaver PC. Trial of phenyoxymethylpenicillin, phenethicillin, and lincomycin in treatment of staphylococcal sepsis in a casualty department. Br Med J. 1968;2:407-9.
37. The macrolides and lincomycin. Br Med J. 1968;3:233-4.
38. Mickal A, Dildy GA, Miller HJ. Lincomycin in the treatment of cervicitis and vagini in pregnancy. South Med J. 1966;59:567-70.
39. Mohr JA, Rhoades ER, Muchmore HG. Actinomycosis treated with lincomycin. JAMA. 1970;212:2260-2.
40. Walker WG. Hypersensitivity reaction in a patient receiving lincomycin. Can Med Assoc J. 1969;101:130.
41. Duncan IB, Jeans B. Lincomycin in hospital practice. Can Med Assoc J. 1965;93:685-91.
42. Raff MJ. Lincomycin: thrombocytopenia? Ann Intern Med. 1973;78:779.
43. Brown EB, Cunningham CE. Granulocytopenia occurring during the administration of lincomycin. JAMA. 1965;194:668-70.
44. Daubeck JL, Daughety MJ, Petty C. Lincomycin-induced cardiac arrest: a case report and laboratory investigation. Anesth Analg. 1974;53:563-7.
45. Waisbren BA. Lincomycin in larger doses. JAMA. 1968;206:2118.
46. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med. 1984;101:92-104.
47. Samuelson RJ, Giesecke AT Jr, Kallus FT, Stanley VF. Lincomycin-curare interaction. Anesth Analg. 1975;54:103-5.
48. Darrell JH, Uttley AH. Antibiotics in the peri-operative period. Br J Anaesth. 1976;48:13-9.
49. Duignan NM, Andrews J, Williams JD. Pharmacological studies with lincomycin in late pregnancy. Br Med J. 1973;3:75-8.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.